Zamansky & Associates LLC notifies all investors in Affymax Inc. (“Affymax”) that it is investigating the recall of Omontys, its anemia treatment for kidney dialysis patients due to reports of...
(PRWeb February 26, 2013)
Read the full story at http://www.prweb.com/releases/2013/2/prweb10467316.htm